Influenza-associated cardiovascular mortality in older adults in Beijing, China: a population-based time-series study
暂无分享,去创建一个
Mark D. Huffman | C. Anderson | M. Huffman | C. Macintyre | Xiaoshuang Liu | P. Yang | Quanyi Wang | Shuangsheng Wu | G. Xie | Tiange Chen | Jianzeng Dong | Jian-ting Su | Xin Du | S. Xia | C. Jiang | Liu He | Zai-hua Wei | Xiang Li | Rong Liu
[1] M. Wong,et al. Ambient temperature, seasonal influenza and risk of cardiovascular disease in a subtropical area in Southern China. , 2020, Environmental research.
[2] S. Li,et al. [The mortality burden of influenza in China: a systematic review]. , 2019, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
[3] Shiwei Liu,et al. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. , 2019, The Lancet. Public health.
[4] F. Zhu,et al. Influenza surveillance in China: a big jump, but further to go. , 2019, The Lancet. Public health.
[5] C. Anderson,et al. Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International. , 2019, Journal of the American College of Cardiology.
[6] Dayan Wang,et al. A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004–2014 , 2019, BMC Public Health.
[7] S. Solomon,et al. Influenza Vaccine in Heart Failure: Cumulative Number of Vaccinations, Frequency, Timing, and Survival A Danish Nationwide Cohort Study , 2019, Circulation.
[8] S. Solomon,et al. Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. , 2018, JACC. Heart failure.
[9] J. Ferreira,et al. Influenza vaccination and prevention of cardiovascular disease mortality , 2018, The Lancet.
[10] J. Cacioppo,et al. The growing problem of loneliness , 2018, The Lancet.
[11] Jan Kyncl,et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.
[12] A. Iuliano,et al. Mortality burden from seasonal influenza and 2009 H1N1 pandemic influenza in Beijing, China, 2007‐2013 , 2017, Influenza and other respiratory viruses.
[13] Ming-Hsien Chiang,et al. Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients , 2017, American heart journal.
[14] S. E. Jensen,et al. Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial. , 2017, American heart journal.
[15] Xiling Wang,et al. Excess mortality associated with influenza after the 2009 H1N1 pandemic in a subtropical city in China, 2010-2015. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[16] Adrian F. Hernandez,et al. Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. , 2017, JACC. Heart failure.
[17] B. Cowling,et al. Edinburgh Research Explorer Seasonal influenza vaccination in China , 2022 .
[18] Kazuhiko Ito,et al. Seasonal Influenza Infections and Cardiovascular Disease Mortality. , 2016, JAMA cardiology.
[19] Peng Yin,et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China , 2015, Bulletin of the World Health Organization.
[20] C. Clar,et al. Influenza vaccines for preventing cardiovascular disease. , 2015, The Cochrane database of systematic reviews.
[21] Bryan R. Smith,et al. Infectious causes of stroke. , 2014, The Lancet. Infectious diseases.
[22] Chun-Yuh Yang,et al. Association of Influenza Vaccination and Reduced Risk of Stroke Hospitalization among the Elderly: A Population-Based Case-Control Study , 2014, International journal of environmental research and public health.
[23] Peng Wu,et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. , 2012, The Journal of infectious diseases.
[24] Cecile Viboud,et al. Improving the Estimation of Influenza-Related Mortality Over a Seasonal Baseline , 2012, Epidemiology.
[25] Weizhong Yang,et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. , 2012, Bulletin of the World Health Organization.
[26] S. Khurana,et al. Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly than in Young Adults and Children , 2012, Journal of Virology.
[27] J. Martínez-Rodríguez,et al. Previous Infection and Stroke: A Prospective Study , 2012, Cerebrovascular Diseases.
[28] Quanyi Wang,et al. Review of an Influenza Surveillance System, Beijing, People’s Republic of China , 2009, Emerging infectious diseases.
[29] P. Heuschmann,et al. Temporal relationship between influenza infections and subsequent first-ever stroke incidence. , 2008, Age and ageing.
[30] N. Ferguson,et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.
[31] H. Krumholz,et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. , 2006, Journal of the American College of Cardiology.
[32] A. Grau,et al. Influenza Vaccination Is Associated With a Reduced Risk of Stroke , 2005, Stroke.
[33] A. Hedley,et al. Influenza-associated mortality in Hong Kong. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] M. Naghavi,et al. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. , 2003, Circulation.
[35] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.